Pierre is a seasoned private equity and venture capital investor as well as an experienced board director. A bilingual executive, with unparalleled leadership and expertise to successfully complete financial transactions in private equity (growth capital, buyout, venture capital) as well as mergers and acquisitions. Recognized, on the Canadian and North American scene, as a "strategic and tactical investor". He is known for making profitable investments as well as for the establishment of efficient multi-disciplinary transactional teams. With an extensive network of national and international contacts with investors, investment banks, financial intermediaries and companies.He pro-actively sought and invested in some of the most well perceived technology based companies in Quebec; biotechnology (Virochem pharma), specialty pharmaceuticals (Aptalis Pharma, Paladin Labs, Searchlight Pharma), medical devices (Orthosoft, Panthera Dental), video games (Ubisoft) and Contract Research Organization (Altasciences). Mr. Cantin also led and executed both investment and divestiture strategies at different firms.Mr. Cantin was co-author and teacher of the first HEC venture capital seminar in Montréal as well as co-author and teacher of the first HEC private equity seminar in Montréal.
Listed skills include Investments, Mergers, Corporate Finance, Debt, and 14 others.